These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 9886492

  • 1. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts.
    Takahashi Y, Akanuma Y, Yazaki Y, Kadowaki T.
    J Cell Physiol; 1999 Jan; 178(1):69-75. PubMed ID: 9886492
    [Abstract] [Full Text] [Related]

  • 2. Multiple in vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584.
    Vogel W, Ullrich A.
    Cell Growth Differ; 1996 Dec; 7(12):1589-97. PubMed ID: 8959326
    [Abstract] [Full Text] [Related]

  • 3. Prolonged vs transient roles for early cell cycle signaling components.
    Rose DW, Xiao S, Pillay TS, Kolch W, Olefsky JM.
    Oncogene; 1998 Aug 20; 17(7):889-99. PubMed ID: 9780005
    [Abstract] [Full Text] [Related]

  • 4. Association of insulin receptor substrate 3 with SH2 domain-containing proteins in rat adipocytes.
    Ross SA, Lienhard GE, Lavan BE.
    Biochem Biophys Res Commun; 1998 Jun 18; 247(2):487-92. PubMed ID: 9642156
    [Abstract] [Full Text] [Related]

  • 5. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
    Wu CJ, O'Rourke DM, Feng GS, Johnson GR, Wang Q, Greene MI.
    Oncogene; 2001 Sep 20; 20(42):6018-25. PubMed ID: 11593409
    [Abstract] [Full Text] [Related]

  • 6. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
    Zhang T, Ma J, Cao X.
    Biochem J; 2003 Dec 01; 376(Pt 2):457-64. PubMed ID: 14498832
    [Abstract] [Full Text] [Related]

  • 7. Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.
    Batty IH, Fleming IN, Downes CP.
    Biochem J; 2004 May 01; 379(Pt 3):641-51. PubMed ID: 14769130
    [Abstract] [Full Text] [Related]

  • 8. SHP-2 regulates the phosphatidylinositide 3'-kinase/Akt pathway and suppresses caspase 3-mediated apoptosis.
    Ivins Zito C, Kontaridis MI, Fornaro M, Feng GS, Bennett AM.
    J Cell Physiol; 2004 May 01; 199(2):227-36. PubMed ID: 15040005
    [Abstract] [Full Text] [Related]

  • 9. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.
    Cui X, Kim HJ, Kuiatse I, Kim H, Brown PH, Lee AV.
    Cancer Res; 2006 May 15; 66(10):5304-13. PubMed ID: 16707456
    [Abstract] [Full Text] [Related]

  • 10. Signaling through the EBV/C3d receptor (CR2, CD21) in human B lymphocytes: activation of phosphatidylinositol 3-kinase via a CD19-independent pathway.
    Bouillie S, Barel M, Frade R.
    J Immunol; 1999 Jan 01; 162(1):136-43. PubMed ID: 9886379
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs).
    Wu CJ, Chen Z, Ullrich A, Greene MI, O'Rourke DM.
    Oncogene; 2000 Aug 17; 19(35):3999-4010. PubMed ID: 10962556
    [Abstract] [Full Text] [Related]

  • 13. Phosphatidylinositol 3-kinase in bovine lens and its stimulation by insulin and IGF-1.
    Chandrasekher G, Bazan HE.
    Invest Ophthalmol Vis Sci; 2000 Mar 17; 41(3):844-9. PubMed ID: 10711702
    [Abstract] [Full Text] [Related]

  • 14. Identification of epidermal growth factor receptor- Grb2-associated binder-1-SHP-2 complex formation and its functional loss during neoplastic cell progression.
    Kameda H, Risinger JI, Han BB, Baek SJ, Barrett JC, Glasgow WC, Eling TE.
    Cell Growth Differ; 2001 Jun 17; 12(6):307-18. PubMed ID: 11432805
    [Abstract] [Full Text] [Related]

  • 15. Specific inhibition of FGF-induced MAPK activation by the receptor-like protein tyrosine phosphatase LAR.
    Wang X, Weng LP, Yu Q.
    Oncogene; 2000 May 04; 19(19):2346-53. PubMed ID: 10822386
    [Abstract] [Full Text] [Related]

  • 16. Effects of growth factors on phosphatidylinositol-3 kinase in astroglial cells.
    Pomerance M, Gavaret JM, Breton M, Pierre M.
    J Neurosci Res; 1995 Apr 15; 40(6):737-46. PubMed ID: 7543159
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Localization and down-regulating role of the protein tyrosine phosphatase PTP2C in membrane ruffles of PDGF-stimulated cells.
    Cossette LJ, Hoglinger O, Mou L, Shen SH.
    Exp Cell Res; 1996 Mar 15; 223(2):459-66. PubMed ID: 8601424
    [Abstract] [Full Text] [Related]

  • 20. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases.
    Ahmad F, Goldstein BJ.
    J Cell Biochem; 1997 Jan 15; 64(1):117-27. PubMed ID: 9015760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.